NO762821L - - Google Patents
Info
- Publication number
- NO762821L NO762821L NO762821A NO762821A NO762821L NO 762821 L NO762821 L NO 762821L NO 762821 A NO762821 A NO 762821A NO 762821 A NO762821 A NO 762821A NO 762821 L NO762821 L NO 762821L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- formula
- hydrogen
- stands
- methanol
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims description 28
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 150000001721 carbon Chemical group 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- -1 cyano, hydroxy Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LIYJKRDVOXIXCP-UHFFFAOYSA-N [amino(methylsulfanyl)methylidene]-(4-chloro-2,1,3-benzothiadiazol-5-yl)azanium;iodide Chemical compound [I-].ClC1=C([NH+]=C(N)SC)C=CC2=NSN=C21 LIYJKRDVOXIXCP-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- QCFGIJDLQHINGA-UHFFFAOYSA-N (4-chloro-2,1,3-benzothiadiazol-5-yl)thiourea Chemical compound ClC1=C(NC(=S)N)C=CC2=NSN=C21 QCFGIJDLQHINGA-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- JRJPKRSKPOCUEV-UHFFFAOYSA-N 2,1,3-benzothiadiazol-5-amine Chemical class C1=C(N)C=CC2=NSN=C21 JRJPKRSKPOCUEV-UHFFFAOYSA-N 0.000 description 1
- JPFOZQOGHFPTOX-UHFFFAOYSA-N 4-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-5-amine Chemical compound C1=CC2=NSN=C2C(Br)=C1NC1=NCCN1 JPFOZQOGHFPTOX-UHFFFAOYSA-N 0.000 description 1
- RAFNDUBDHJMEDU-UHFFFAOYSA-N 4-chloro-2,1,3-benzothiadiazol-5-amine Chemical compound ClC1=C(N)C=CC2=NSN=C21 RAFNDUBDHJMEDU-UHFFFAOYSA-N 0.000 description 1
- VQAAFLJYBUOSEN-UHFFFAOYSA-N 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-5-amine Chemical compound C1=CC2=NSN=C2C(Cl)=C1NC1=NCCN1 VQAAFLJYBUOSEN-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- JTNYROYIAZZSOG-UHFFFAOYSA-N n-[(4-chloro-2,1,3-benzothiadiazol-5-yl)carbamothioyl]benzamide Chemical compound C1=CC2=NSN=C2C(Cl)=C1NC(=S)NC(=O)C1=CC=CC=C1 JTNYROYIAZZSOG-UHFFFAOYSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Fremgangsmåte for fremstilling av nye organiske' forbindelser.Process for the preparation of new organic compounds.
Description
Foreliggende oppfinnelse vedrører en fremgangsmåte for fremstilling av nye forbindelser med formel I The present invention relates to a method for the production of new compounds of formula I
hvori R^, R 2 og R^uavhengig av hverandre står for hydrogen, halogen, nitro, cyano, hydroksy, alkyl, alkoksy eller alkyltio, idet alkylgruppene har 1-4 karbonatomer, og deres tautomere former. in which R^, R 2 and R^ independently of each other stand for hydrogen, halogen, nitro, cyano, hydroxy, alkyl, alkoxy or alkylthio, the alkyl groups having 1-4 carbon atoms, and their tautomeric forms.
I forbindelsene med formel I betyr halogen i det enkelte tilfelle fluor, klor, brom eller jod, foretrukket brom eller klor. Alkyl, alkoksy og alkyltio inneholder foretrukket 1-2 karbonatomer. Foretrukket betyr en eller to av substituentene R^, Rg eller R^hydrogen. R^står spesielt for halogen. R^betyr spesielt hydrogen, halogen eller metyl. står spesielt for hydrogen, metyl eller klor. In the compounds of formula I, halogen in the individual case means fluorine, chlorine, bromine or iodine, preferably bromine or chlorine. Alkyl, alkoxy and alkylthio preferably contain 1-2 carbon atoms. Preferably, one or two of the substituents R^, Rg or R^ means hydrogen. R^ specifically stands for halogen. R^ means in particular hydrogen, halogen or methyl. stands for hydrogen, methyl or chlorine in particular.
Forbindelsene med formel I kan opptre i deres tautomere form, som gjengis ved formel Ia The compounds of formula I may exist in their tautomeric form, which is represented by formula Ia
for enkelthets skyld sammenfattes forbindelsene med formel I og Ia under formel I. Det samme gjelder for de i det følgende nevnte utgangsforbindelser med formel II og III. for the sake of simplicity, the compounds of formula I and Ia are summarized under formula I. The same applies to the starting compounds of formula II and III mentioned below.
Det særegne ved fremgangsmåten i henhold til oppfinnelsen for fremstilling av forbindelsene med formel I er at forbindelser med formel- II The peculiarity of the method according to the invention for producing the compounds of formula I is that compounds of formula II
hvori R^, R^og R^har den ovennevnte betydning, og enten A wherein R^, R^ and R^ have the above meaning, and either A
står for hydrogen og B, Z og: X sammen med det karbonatom, hvortil de er bundet, står for gruppen -C=N, eller A og B betyr sammen en andre binding mellom nitrogen- og karbonatomet, og X og Z stands for hydrogen and B, Z and: X, together with the carbon atom to which they are attached, stands for the group -C=N, or A and B together mean a second bond between the nitrogen and carbon atoms, and X and Z
står i det enkelte tilfelle uavhengig av hverandre for en avspaltbar gruppe, eller deres tautomere form.omsettes med etylendiamin. stand in each case independently of each other for a cleavable group, or their tautomeric form. are reacted with ethylenediamine.
De ved fremgangsmåten i henhold til oppfinnelsen fremstillbare forbindelser med formel I kan overføres i sine salter og omvendt. The compounds of formula I which can be prepared by the method according to the invention can be transferred into their salts and vice versa.
Fremgangsmåten kan gjennomføres på en for fremstilling avThe method can be carried out on a for the production of
analoge forbindelser kjent måte, f.eks. fremgangsmåten i henhold til DOS 2.322.880. analogous compounds in a known manner, e.g. the procedure according to DOS 2,322,880.
X og Z er enten like eller forskjellige og betyr hensiktsmessigX and Z are either the same or different and mean appropriately
en R4S-, en R^NH-, en R40- eller C^NHN-gruppen.^hvori R4står for hydrogen eller en alkylgruppe med 1-3 karbonatomer, eller de betyr i det enkelte tilfelle klor. Foretrukket står X for SCH^og Z for NH2. an R4S-, an R^NH-, an R40- or C^NHN group.^wherein R4 stands for hydrogen or an alkyl group with 1-3 carbon atoms, or they mean chlorine in the individual case. Preferably, X stands for SCH^ and Z for NH2.
Foretrukket anvender man et syreaddisjonssalt av forbindelsene med formel II, f.eks. hydrojodidet, og etylendiamin i form av fri base, el'L"er forbindelsen med førmel II i form av den fri base og et monosyreaddisjonssalt av etylendiaminet, f.eks. tosylatet. An acid addition salt of the compounds of formula II is preferably used, e.g. the hydroiodide, and ethylenediamine in the form of the free base, or L"is the compound with formula II in the form of the free base and a monoacid addition salt of the ethylenediamine, e.g. the tosylate.
Fremgangsmåten gjennomføres hensiktsmessig ved temperaturerThe procedure is suitably carried out at temperatures
mellom 0 og 200°C, foretrukket mellom 60 og 160°C. Som løsningsmiddel egner seg alkoholer med 1-8 karbonatomer, som metanol, etanol eller n-pentanol, dioksan, nitrobenzen eller xylen. between 0 and 200°C, preferably between 60 and 160°C. Suitable solvents are alcohols with 1-8 carbon atoms, such as methanol, ethanol or n-pentanol, dioxane, nitrobenzene or xylene.
Forbindelsene med formel I kan isoleres og renses på i og forThe compounds of formula I can be isolated and purified in and for
seg kjent måte.known way.
Det antas at ved fremgangsmåten i henhold til oppfinnelsen dannes mellomforbindelser med formel III hvori R^, R^, R^°9Z har den ovennevnte betydning, eller deres tautomerer, som ved ringslutning danner forbindelsene med formel I. It is assumed that the method according to the invention forms intermediate compounds of formula III in which R^, R^, R^°9Z have the above-mentioned meaning, or their tautomers, which form the compounds of formula I by ring closure.
Et spesialtilfelle av fremgangsmåten i henhold til oppfinnelsenA special case of the method according to the invention
er således en fremgangsmåte for fremstilling av forbindelser med formel I ved ringslutning av forbindelser med formel III. is thus a method for preparing compounds of formula I by cyclization of compounds of formula III.
Fremgangsmåten kan gjennomføres på en for ringslutningsreaksjoner kjent måte. F.eks. kan de ovenfor angitte foretrukne verdier for Z, løsningsmiddel og temperaturer anvendes. Forbindelsene'med formel III dannes foretrukket in situ fra forbindelser med formel II'.> The method can be carried out in a manner known for ring closure reactions. E.g. the above stated preferred values for Z, solvent and temperatures can be used. The compounds of formula III are preferably formed in situ from compounds of formula II
men kan også fremstilles fra andre forbindelser.but can also be produced from other compounds.
Utgangsforbindelsene med formel II kan fremstilles analogt medThe starting compounds of formula II can be prepared analogously to
i og for seg kjente metoder, f.eks.- metoden i henhold til DOS 2.322.880 under anvendelse a.v 5-amino-2,1, 3-benzotiadiazol-derivater. per se known methods, e.g. the method according to DOS 2,322,880 using 5-amino-2,1,3-benzothiadiazole derivatives.
De basiske forbindelser med formel -.1 kan ved omsetning med egnede uorganiske eller organiske syrer overføres i sine syreaddisjonssalter. For. dette egner seg som uorganiske syrer f.eks. saltsyre og som organiske syrer f. eks. eddik syr eyi maleinsyre, etc: De ved fremgangsmåten i henhold til oppfinnelsen fremstillbare forbindelser med formel I utmerker seg ved farmakodynamiske egenskaper. Spesielt virker forbindelsene med formel I mot rigor og myotonolytisk. The basic compounds of formula -.1 can be converted into their acid addition salts by reaction with suitable inorganic or organic acids. For. this is suitable as inorganic acids, e.g. hydrochloric acid and as organic acids, e.g. acetic acid eyi maleic acid, etc.: The compounds of formula I which can be prepared by the method according to the invention are distinguished by their pharmacodynamic properties. In particular, the compounds of formula I act against rigor and myotonolytic.
Forbindelsene med formel I kan likeledes tilføres i form avThe compounds of formula I can also be supplied in the form of
sine syreaddisjonssalter, som har den samme grad av aktivitet som de fri baser. their acid addition salts, which have the same degree of activity as the free bases.
N N
Tilførselen av forbindelsene med formel I henhv. deres salterThe supply of the compounds of formula I respectively their salts
kan skje enten oralt i form av tabletter, granulater, kapsler eller drageer eller parenteralt i form av injeksjonsløsninger. can take place either orally in the form of tablets, granules, capsules or dragees or parenterally in the form of injection solutions.
I de følgende eksempler er temperaturene angitt-i °C og erIn the following examples, the temperatures are indicated in °C and are
ukorrigert.uncorrected.
EKSEMPEL 1 : 4-klor-5-( 2-imidazolin-2-ylamino)-2 ,1, 3-benzotiadiazolEXAMPLE 1 : 4-chloro-5-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole
En løsning av 9,5 g S-metyl-N-(4-klor-2,1,3-benzotiadiazol-5-yl)-isotiuroniumjodid i 70 ml metanol tilsettes 1,7 ml etylendiamin og blandingen oppvarmes til koking i 1 time. Deretter avdampes løsningsmidlet, resten tilsettes 10 ml n-pentanol og oppvarmes i 1 time ved 15_0°C. Den avkjølte blanding fortynnes ved 100 ml eter, bunnfallet filtreres og vasked med litt eter. Resten løses i 70 ml metanol, løsningen behandles med aktivtkull, filteres, innstilles alkalisk med 2N vandig natriumhydroksydløsning,. fortynnes med 100 ml vann og inndampes til det halve vol.um. Etter avkjøling frafiltreres det dannede bunnfall, vaske.s med vann og kokes opp med 200 ml metanol, idet man ved avkjøling kommer frem til den i overskriften nevnte forbindelse med smeltepunkt 232-235°C. A solution of 9.5 g of S-methyl-N-(4-chloro-2,1,3-benzothiadiazol-5-yl)-isothiuronium iodide in 70 ml of methanol is added with 1.7 ml of ethylenediamine and the mixture is heated to boiling for 1 hour . The solvent is then evaporated, 10 ml of n-pentanol is added to the residue and heated for 1 hour at 15_0°C. The cooled mixture is diluted with 100 ml of ether, the precipitate is filtered and washed with a little ether. The residue is dissolved in 70 ml of methanol, the solution is treated with activated charcoal, filtered, made alkaline with 2N aqueous sodium hydroxide solution. diluted with 100 ml of water and evaporated to half the volume. After cooling, the precipitate formed is filtered off, washed with water and boiled with 200 ml of methanol, upon cooling the compound mentioned in the title is reached with a melting point of 232-235°C.
Det i dette eksempel anvendte utgangsmaterial erholdes på følgende måte: The starting material used in this example is obtained in the following way:
En løsning av 6 g ammoniumrodanid i 200 ml aceton tilsettes iA solution of 6 g of ammonium rhodanide in 200 ml of acetone is added
isbad 7 ml benzoylklorid og omrøres i 10 min. Til denne løsning tilsettes en løsning av 6 g 4-klor-5-amino-2,1,3-benzotiadiazol i 200 ml metanol og blandingen oppvarmes til koking i 2 timer og avkjøles ice bath 7 ml benzoyl chloride and stir for 10 min. To this solution is added a solution of 6 g of 4-chloro-5-amino-2,1,3-benzothiadiazole in 200 ml of methanol and the mixture is heated to boiling for 2 hours and cooled
deretter, hvprved N-benzoyl-N'-(4-klor-2,1,3-benzotiadiazol-5-yl)-tiourinstoff (smeltepunkt 220-222°C fra metanol) faller ut. Bunnfallet frafiltreres og bringes hurtig til koking med 100 ml', then, hvprved N-benzoyl-N'-(4-chloro-2,1,3-benzothiadiazol-5-yl)-thiourea (m.p. 220-222°C from methanol) precipitates. The precipitate is filtered off and quickly brought to the boil with 100 ml',
av en 2N vandig natriumhy.éfoksydløsning. Etter 5 minutter koketid avkjøles løsningen, filtreres og syres svakt med iseddik. Det dannedéj/bunnf all f raf il treres, vaskes med vann, kokes ut med litt metanol og vaskes med eter. Det således erholdte N-(4-klor-2,1,3-benzotiadiazol-5-yl)-tiourinstoff (smeltepunkt 210-213°C) oppvarmes til', koking i 1 time med 5 g metyl jodid i 100 ml metanol og blandingen inndampes deretter til tørrhet, hvorved man erholder rått S-metyl-N-(4-klor-2,1,3-benzotiadiazol-5-yl)-isotiuroniumjodid (smeltepunkt 175-179°C fra metanol) som anvendes uten ytterligere rensing i den foregående reaksjon. of a 2N aqueous sodium hydroxide solution. After 5 minutes of boiling, the solution is cooled, filtered and slightly acidified with glacial acetic acid. The resulting cake/precipitate is filtered, washed with water, boiled off with a little methanol and washed with ether. The thus obtained N-(4-chloro-2,1,3-benzothiadiazol-5-yl)-thiourea (melting point 210-213°C) is heated to boiling for 1 hour with 5 g of methyl iodide in 100 ml of methanol and the mixture is then evaporated to dryness, whereby crude S-methyl-N-(4-chloro-2,1,3-benzothiadiazol-5-yl)-isothiuronium iodide (m.p. 175-179°C from methanol) is obtained which is used without further purification in the preceding reaction.
EKSEMPEL 2EXAMPLE 2
Analogt eksempel 1 og under anvendelse av tilsvarende utgangsmaterialer i omtrent ekvivalente mengder kan man komme frem til følgende forbindelser med formel I: a) 5-(2-imådazolin_2-yl-amino)-2,1,3-benzotiadiazol med smeltepunkt 200-201°C, Analogous to example 1 and using corresponding starting materials in approximately equivalent quantities, the following compounds of formula I can be arrived at: a) 5-(2-imådazolin_2-yl-amino)-2,1,3-benzothiadiazole with melting point 200-201 °C,
b) 4-brom-5-(2-imidazolin-2-yl-amino)-2,1,3-benzotiadiazolb) 4-bromo-5-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole
med smeltepunkt 234-236°C. with melting point 234-236°C.
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1091175A CH613966A5 (en) | 1975-08-22 | 1975-08-22 | Process for the preparation of novel 5-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
NO762821L true NO762821L (en) | 1977-02-23 |
Family
ID=4368128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO762821A NO762821L (en) | 1975-08-22 | 1976-08-13 |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5225774A (en) |
AU (1) | AU1707076A (en) |
BE (1) | BE845409A (en) |
CH (1) | CH613966A5 (en) |
DE (1) | DE2636309A1 (en) |
DK (1) | DK368376A (en) |
ES (1) | ES450875A1 (en) |
FI (1) | FI762321A (en) |
FR (1) | FR2321287A1 (en) |
GB (1) | GB1552163A (en) |
IL (1) | IL50324A0 (en) |
NL (1) | NL7609156A (en) |
NO (1) | NO762821L (en) |
NZ (1) | NZ181819A (en) |
PT (1) | PT65504B (en) |
SE (1) | SE7609085L (en) |
YU (1) | YU201976A (en) |
ZA (1) | ZA765016B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4217356A (en) * | 1975-08-22 | 1980-08-12 | Sandoz Ltd. | 2-Imidazolinylamino-2,1,3-benzothiadiazoles |
JPS54151761U (en) * | 1978-04-12 | 1979-10-22 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH570401A5 (en) * | 1972-05-09 | 1975-12-15 | Wander Ag Dr A |
-
1975
- 1975-08-22 CH CH1091175A patent/CH613966A5/en not_active IP Right Cessation
-
1976
- 1976-08-12 FR FR7624660A patent/FR2321287A1/en active Granted
- 1976-08-12 DE DE19762636309 patent/DE2636309A1/en not_active Withdrawn
- 1976-08-13 SE SE7609085A patent/SE7609085L/en unknown
- 1976-08-13 NO NO762821A patent/NO762821L/no unknown
- 1976-08-13 DK DK368376A patent/DK368376A/en unknown
- 1976-08-13 FI FI762321A patent/FI762321A/fi not_active Application Discontinuation
- 1976-08-18 NL NL7609156A patent/NL7609156A/en not_active Application Discontinuation
- 1976-08-19 YU YU02019/76A patent/YU201976A/en unknown
- 1976-08-20 NZ NZ181819A patent/NZ181819A/en unknown
- 1976-08-20 GB GB34757/76A patent/GB1552163A/en not_active Expired
- 1976-08-20 IL IL50324A patent/IL50324A0/en unknown
- 1976-08-20 ZA ZA00765016A patent/ZA765016B/en unknown
- 1976-08-20 JP JP51098843A patent/JPS5225774A/en active Pending
- 1976-08-20 ES ES450875A patent/ES450875A1/en not_active Expired
- 1976-08-20 BE BE169990A patent/BE845409A/en not_active IP Right Cessation
- 1976-08-20 PT PT65504A patent/PT65504B/en unknown
- 1976-08-23 AU AU17070/76A patent/AU1707076A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
YU201976A (en) | 1982-05-31 |
ZA765016B (en) | 1978-03-29 |
AU1707076A (en) | 1978-03-02 |
GB1552163A (en) | 1979-09-12 |
FR2321287B1 (en) | 1978-11-17 |
BE845409A (en) | 1977-02-21 |
PT65504B (en) | 1978-05-10 |
FR2321287A1 (en) | 1977-03-18 |
DK368376A (en) | 1977-02-23 |
NL7609156A (en) | 1977-02-24 |
IL50324A0 (en) | 1976-10-31 |
NZ181819A (en) | 1978-06-02 |
CH613966A5 (en) | 1979-10-31 |
JPS5225774A (en) | 1977-02-25 |
FI762321A (en) | 1977-02-23 |
PT65504A (en) | 1976-09-01 |
DE2636309A1 (en) | 1977-03-03 |
SE7609085L (en) | 1977-02-23 |
ES450875A1 (en) | 1978-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO164335B (en) | MIXING, BINDING AND USING THE BINDING ON COLLAGENT MATERIAL. | |
NO331775B1 (en) | Modified Pictet-Spengler reaction and product prepared therefrom | |
SU493966A3 (en) | The method of obtaining 4- / 2-imidazolin-2-ylamino / -2,1,3-benzothiadiazole derivatives | |
DK146205B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF 8ALFA ERGOLIN-I DERIVATIVES | |
NO165343B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE 3- (2-AMINOETHYL) INDOLES. | |
NO764039L (en) | ||
SU566524A3 (en) | Method of obtaining derivatives of pyrido-(1,2-alpha)-pyrimidine and their salts | |
NO752493L (en) | ||
NO762821L (en) | ||
JP2023159297A (en) | Method for producing diarylpyridine derivatives | |
Dumitraşcu et al. | Steric effects on the sydnones reactivity. New sydnones and pyrazoles | |
Selms | Benzimidazoles. II. Synthesis of N-heterocyclic ring systems containing 1, 2-fused benzimidazole moieties | |
JPS6284083A (en) | N-alkylation of dihydrolysergic acid | |
US2759932A (en) | Series of new n-(5-nitro-2-furfurylidene)-3-amino-2-iminooxazolidines | |
SU858316A1 (en) | 2,5-di-(n-aminophenyl)pyramidine as monomer for synthesis of polymides,method of producing same and polyimides on its base as heat resistant material | |
SU419028A3 (en) | METHOD OF OBTAINING 2- | |
JPS5811878B2 (en) | Furo (3 2-B) India-Ruruino Seihou | |
SU588915A3 (en) | Method of preparing acetamidoximes | |
US2524800A (en) | Hydroxybenzenesulfonamidoheterocycles and preparation of same | |
RU2435774C1 (en) | Ethyl-2-amino-7,7-dimethyl-2',5-dioxo-5'-phenyl-1',2',5,6,7,8-hexahydrospiro[chromen-4,3'-pyrrol]-4'-carboxylates and method for producing them | |
US4219651A (en) | Benzimidazo-[1,2-a]-quinolines | |
JPS5944312B2 (en) | Production method of indazole derivatives | |
KR950009753B1 (en) | N1-substituted 1h-benzytriazole hydroxyethyl suhone compounds,a process for their preparation and their use for the preparation of dyestudds | |
Angyal et al. | Sulphonamides. III. Disulphonyl Derivatives of some N-Heterocyclic Amines | |
SU513626A3 (en) | Method for preparing 4- (2-imidazolinyl-2-amino) -2,1,3-benzothiadiazole derivatives |